Daniel M. Spevack, MD

NPI 1417038837ActiveIndividual· Internal Medicine, Cardiovascular Disease· Valhalla, NY

Internal Medicine, Cardiovascular Disease (MD) in Valhalla, New York, trained at New York University School of Medicine (class of 1997). Their prescriptions cost Medicare Part D more than their services did: $147,608 for 826 claims, against $82,764 paid for services in 2024. Abbott Laboratories was the largest of 2 companies reporting payments in 2025, $1,689 in all, mostly travel and lodging.

Overview

NPI	1417038837
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Oct 19, 2006
Last updated in NPPES	Nov 29, 2021
Certified by provider	Nov 29, 2021

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Cardiovascular Disease Primary	207RC0000X	210762	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Cardiovascular Disease (Cardiology) (NY)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	955
Services billed	1,816 across 33 procedure codes
Paid by Medicare	$82,764

Part D prescriptions in 2024

Prescriptions (claims)	826 · 2,141 30-day fills
Patients	124
Total drug cost	$147,608
Generic share	86% of claims

Medicare sources and data years

Education and affiliations

Medical school	New York University School of Medicine
Graduation year	1997
Medicare specialty	Cardiovascular Disease (Cardiology)
Secondary specialties	Internal Medicine